Your Health is Our #1 Priority
October 2007 | Year 8: Issue 10  

Newsletter Home > Americans Are Fed Up With FDA Corruption

Americans Are Fed Up With FDA Corruption

More than four out of five Americans think drug companies have too much influence over the Food and Drug Administration, and 84 percent believe that advertisements for prescription drugs with safety concerns should be outlawed, reveals a striking new survey from Consumer Reports.

The survey results, released today, are based on a telephone survey of 1,026 American adults conducted by the Consumer Reports National Research Center. They reveal the Food and Drug Administration to be alarmingly out of touch with the concerns of the American people. Some of the most interesting results include:

  • 96 percent agreed the government should have the power to require warning labels on drugs with known safety problems. As Consumer Reports explains, "Right now, the Food and Drug Administration must negotiate safety warning labels with a drug maker."
  • 84 percent agree that drug companies have "too much influence over the government officials who regulate them." More than two-thirds of those surveyed are concerned that drug companies actually pay the FDA to review and approve their drugs. It's a situation that turns drug companies into the "customers" of the FDA. (See related cartoon, The Puppets of Big Pharma)
  • 92 percent agree that pharmaceutical companies should disclose the results of ALL clinical trials, not just the ones with positive results that they wish to publicize. (Currently, drug companies can bury negative drug trials, and the FDA has in fact been caught conspiring with drug companies to keep negative drug data secret from the public.)
  • 93 percent think that the FDA should have the power to demand follow-up safety studies from drug companies. Currently, the FDA has no authority to require follow-up safety studies on drugs after they are introdued to the market. This is a serious oversight shortfall, given that many problems with drugs only appear after widespread use. (Patients are widely used as guinea pigs in any new drug launch.)

Read the full article at Newstarget.com

Monthly Specials